120 related articles for article (PubMed ID: 29207712)
1. Role of
Bajpai S; Awasthi S; Dutta S; Mittal A; Kumar A; Ahmad F
J Clin Diagn Res; 2017 Sep; 11(9):EC01-EC04. PubMed ID: 29207712
[TBL] [Abstract][Full Text] [Related]
2. HER-2/neu expression in lesions of uterine cervix: is it reliable and consistent?
Gupta N; Singh S; Marwah N; Kumar S; Chabra S; Sen R
Indian J Pathol Microbiol; 2009; 52(4):482-5. PubMed ID: 19805951
[TBL] [Abstract][Full Text] [Related]
3. Role and significance of HER-2/neu as a biomarker in the premalignant and malignant lesions of uterine cervix.
Varshney S; Maheshwari V; Aijaz M; Alam K
Ann Diagn Pathol; 2020 Apr; 45():151443. PubMed ID: 31923745
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical study of retinoblastoma gene product in normal, premalignant and malignant tissues of the uterine cervix.
Noraini MD; Siti-Aishah MA; Kwan SW
Malays J Med Sci; 2003 Jan; 10(1):52-9. PubMed ID: 23365501
[TBL] [Abstract][Full Text] [Related]
5. p53 and bcl2 expression in malignant and premalignant lesions of uterine cervix and their correlation with human papilloma virus 16 and 18.
Shukla S; Dass J; Pujani M
South Asian J Cancer; 2014 Jan; 3(1):48-53. PubMed ID: 24665447
[TBL] [Abstract][Full Text] [Related]
6. The differential expression of the HER-2/neu oncogene among high-risk human papillomavirus-infected glandular lesions of the uterine cervix.
Roland PY; Stoler MH; Broker TR; Chow LT
Am J Obstet Gynecol; 1997 Jul; 177(1):133-8. PubMed ID: 9240596
[TBL] [Abstract][Full Text] [Related]
7. Expression of p16INK4A Protein in Cervical Intraepithelial Neoplasia and Invasive Carcinoma of Uterine Cervix.
Kishore V; Patil AG
J Clin Diagn Res; 2017 Sep; 11(9):EC17-EC20. PubMed ID: 29207716
[TBL] [Abstract][Full Text] [Related]
8. HER-2/neu expression in pancreatic adenocarcinoma: relation to tumor differentiation and survival.
Dugan MC; Dergham ST; Kucway R; Singh K; Biernat L; Du W; Vaitkevicius VK; Crissman JD; Sarkar FH
Pancreas; 1997 Apr; 14(3):229-36. PubMed ID: 9094152
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma.
Khan AJ; King BL; Smith BD; Smith GL; DiGiovanna MP; Carter D; Haffty BG
Clin Cancer Res; 2002 Feb; 8(2):540-8. PubMed ID: 11839675
[TBL] [Abstract][Full Text] [Related]
10. HER2/neu (c-erbB-2) gene amplification and protein expression are rare in uterine cervical neoplasia: a tissue microarray study of 814 archival specimens.
Lesnikova I; Lidang M; Hamilton-Dutoit S; Koch J
APMIS; 2009 Oct; 117(10):737-45. PubMed ID: 19775342
[TBL] [Abstract][Full Text] [Related]
11. Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina.
Berchuck A; Rodriguez G; Kamel A; Soper JT; Clarke-Pearson DL; Bast RC
Obstet Gynecol; 1990 Sep; 76(3 Pt 1):381-7. PubMed ID: 1974342
[TBL] [Abstract][Full Text] [Related]
12. HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system.
Ciampa A; Xu B; Ayata G; Baiyee D; Wallace J; Wertheimer M; Edmiston K; Khan A
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):132-7. PubMed ID: 16785779
[TBL] [Abstract][Full Text] [Related]
13. Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma.
Lee EY; Cibull ML; Strodel WE; Haley JV
Arch Pathol Lab Med; 1994 Mar; 118(3):235-9. PubMed ID: 7907854
[TBL] [Abstract][Full Text] [Related]
14. Role of EGFR and HER-2/NEU Expression in Gall Bladder Carcinoma (GBC).
Das C; Mukhopadhyay M; Subba S; Saha AK; Mukhopadhyay B
J Lab Physicians; 2021 Mar; 13(1):29-35. PubMed ID: 34103877
[No Abstract] [Full Text] [Related]
15. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
16. Her2/neu Protein Expression and Oncogene Amplification in Gastric Carcinoma with Clinico-Pathological Correlation in Egyptian Patients.
Hadi AA; Hindawi AE; Hareedy A; Khalil H; Ashiry RA; Elia S; Sadek A; Magdy M; Atta R; Anas A; Bakr H; Hammam O
Open Access Maced J Med Sci; 2016 Dec; 4(4):535-542. PubMed ID: 28028387
[TBL] [Abstract][Full Text] [Related]
17. Alteration in key oncoprotein expression in gastric adenocarcinoma - An immunohistochemical study.
Jain P; Wadhwa N; Diwaker P; Joshi MK; Mishra K
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147954
[TBL] [Abstract][Full Text] [Related]
18. Expression of Human Epidermal Growth Factor Receptor (Her 2/neu) and Proliferative Marker Ki-67: Association with Clinicopathological Parameters in Gallbladder Carcinoma.
Pujani M; Makker I; Makker A; Jetley S; Goel MM; Jetley S
Asian Pac J Cancer Prev; 2016; 17(8):3903-9. PubMed ID: 27644637
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase pi is expressed in (pre) neoplastic lesions of the human uterine cervix irrespective of their degree of severity.
Martens JE; Smedts F; ter Harmsel B; Helmerhorst TJ; Ramaekers FC
Anticancer Res; 1997; 17(6D):4305-9. PubMed ID: 9494525
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of her-2/neu amplification/overexpression in OSCC with fluorescence in situ hybridization (FISH) and immunohistochemistry].
Scheer M; Prange W; Petmecky K; Schirmacher P; Zöller JE; Kübler AC
Mund Kiefer Gesichtschir; 2003 May; 7(3):138-45. PubMed ID: 12764679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
